The objective of this study was to investigate the factors underlying the development of
metabolic syndrome (MetS) in HIV-infected patients. Two hundred and sixty-six clinical …

Background. The association between the use of highly active antiretroviral therapy
(HAART) and an increased risk of metabolic syndrome and cardiovascular disease remains …

Objectives The aim of this study was to assess the incidence of being overweight and
metabolic syndrome (MS) among people living with HIV (PHIV) in three different cross …

Metabolic syndrome (MetS) is associated with development of type 2 diabetes mellitus and
increased risk for cardiovascular disease. However, a few studies have assessed its …

Objective: To compare the prevalence of metabolic syndrome (MS) in HIV-positive patients
with that from a sample of a general Italian population. Design: Cross-sectional study …

Objectives. We determined metabolic syndrome (MetS) prevalence and assessed the
agreement between different diagnostic criteria in HIV‐infected South Africans. Method. A …

The study by Mondy et al.[1] in this issue of Clinical Infectious Diseases addresses the
development of metabolic syndrome (diagnosed using National Cholesterol Education …

Background: Metabolic syndrome increases the risk of cardiovascular outcomes and type II
diabetes. Most of the metabolic abnormalities defining metabolic syndrome are observed in …

HERMES is a prospective study, including all treatment-naive patients attending scheduled
visits at hospitals in the CISAI group in 2007. The present cross-sectional analysis aims to …

Introduction Chronic viral replication has been linked to an increased risk of cardiovascular
and metabolic diseases in people living with HIV (PLWH), but few studies have evaluated …